West Pharmaceutical Services, Inc. (WST)
USD 230.77
(2.09%)
USD 230.77
(2.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 454 Million USD | 4.87% |
| 2022 | 402.2 Million USD | -5.03% |
| 2021 | 423.5 Million USD | 17.35% |
| 2020 | 360.9 Million USD | 15.82% |
| 2019 | 311.6 Million USD | 2.77% |
| 2018 | 303.2 Million USD | 7.63% |
| 2017 | 281.7 Million USD | 1.84% |
| 2016 | 276.6 Million USD | 3.56% |
| 2015 | 267.1 Million USD | 0.41% |
| 2014 | 266 Million USD | -2.49% |
| 2013 | 272.8 Million USD | 8.56% |
| 2012 | 251.3 Million USD | 13.35% |
| 2011 | 221.7 Million USD | 3.94% |
| 2010 | 213.3 Million USD | 7.95% |
| 2009 | 197.6 Million USD | 2.97% |
| 2008 | 191.9 Million USD | 13.82% |
| 2007 | 168.6 Million USD | 4.85% |
| 2006 | 160.8 Million USD | 32.13% |
| 2005 | 121.7 Million USD | 14.06% |
| 2004 | 106.7 Million USD | 13.15% |
| 2003 | 94.3 Million USD | 16.42% |
| 2002 | 81 Million USD | 12.66% |
| 2001 | 71.9 Million USD | -31.33% |
| 2000 | 104.7 Million USD | -7.83% |
| 1999 | 113.6 Million USD | 10.51% |
| 1998 | 102.8 Million USD | 0.69% |
| 1997 | 102.1 Million USD | -1.35% |
| 1996 | 103.5 Million USD | 4.02% |
| 1995 | 99.5 Million USD | 8.03% |
| 1994 | 92.1 Million USD | 7.72% |
| 1993 | 85.5 Million USD | 5.95% |
| 1992 | 80.7 Million USD | -26.3% |
| 1991 | 109.5 Million USD | 36.02% |
| 1990 | 80.5 Million USD | 22.15% |
| 1989 | 65.9 Million USD | 9.11% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 100.5 Million USD | -6.42% |
| 2024 Q3 | 99 Million USD | -1.49% |
| 2024 Q1 | 107.4 Million USD | -0.92% |
| 2023 Q2 | 104.9 Million USD | -9.57% |
| 2023 Q1 | 116 Million USD | -12.39% |
| 2023 FY | 421.8 Million USD | 4.87% |
| 2023 Q3 | 105.4 Million USD | 0.48% |
| 2023 Q4 | 108.4 Million USD | 2.85% |
| 2022 Q2 | 95.9 Million USD | -2.14% |
| 2022 FY | 402.2 Million USD | -5.03% |
| 2022 Q1 | 98 Million USD | -15.95% |
| 2022 Q4 | 132.4 Million USD | 65.71% |
| 2022 Q3 | 79.9 Million USD | -16.68% |
| 2021 Q4 | 116.6 Million USD | 11.05% |
| 2021 FY | 423.5 Million USD | 17.35% |
| 2021 Q1 | 92.4 Million USD | -2.74% |
| 2021 Q2 | 103.8 Million USD | 12.34% |
| 2021 Q3 | 105 Million USD | 1.16% |
| 2020 FY | 360.9 Million USD | 15.82% |
| 2020 Q2 | 88.5 Million USD | 12.03% |
| 2020 Q1 | 79 Million USD | -0.25% |
| 2020 Q3 | 88.7 Million USD | 0.23% |
| 2020 Q4 | 95 Million USD | 7.1% |
| 2019 Q2 | 79.9 Million USD | 1.91% |
| 2019 Q1 | 78.4 Million USD | 12.81% |
| 2019 Q3 | 74.1 Million USD | -7.26% |
| 2019 Q4 | 79.2 Million USD | 6.88% |
| 2019 FY | 311.6 Million USD | 2.77% |
| 2018 Q4 | 69.5 Million USD | -7.33% |
| 2018 Q1 | 77.9 Million USD | 13.56% |
| 2018 Q2 | 80.8 Million USD | 3.72% |
| 2018 Q3 | 75 Million USD | -7.18% |
| 2018 FY | 303.2 Million USD | 7.63% |
| 2017 Q2 | 70.6 Million USD | -1.81% |
| 2017 Q1 | 71.9 Million USD | 1.99% |
| 2017 Q3 | 70.6 Million USD | 0.0% |
| 2017 Q4 | 68.6 Million USD | -2.83% |
| 2017 FY | 281.7 Million USD | 1.84% |
| 2016 Q2 | 71.3 Million USD | 5.63% |
| 2016 FY | 276.6 Million USD | 3.56% |
| 2016 Q3 | 67.3 Million USD | -5.61% |
| 2016 Q1 | 67.5 Million USD | -6.77% |
| 2016 Q4 | 70.5 Million USD | 4.75% |
| 2015 Q1 | 62.7 Million USD | -5.86% |
| 2015 FY | 267.1 Million USD | 0.41% |
| 2015 Q2 | 79.8 Million USD | 27.27% |
| 2015 Q3 | 63.1 Million USD | -20.93% |
| 2015 Q4 | 72.4 Million USD | 14.74% |
| 2014 Q3 | 65.6 Million USD | -2.67% |
| 2014 FY | 266 Million USD | -2.49% |
| 2014 Q1 | 66.4 Million USD | -4.73% |
| 2014 Q2 | 67.4 Million USD | 1.51% |
| 2014 Q4 | 66.6 Million USD | 1.52% |
| 2013 Q3 | 65.7 Million USD | -5.06% |
| 2013 FY | 272.8 Million USD | 8.56% |
| 2013 Q4 | 69.7 Million USD | 6.09% |
| 2013 Q2 | 69.2 Million USD | 1.47% |
| 2013 Q1 | 68.2 Million USD | 1.49% |
| 2012 Q1 | 58.8 Million USD | 9.91% |
| 2012 FY | 251.3 Million USD | 13.35% |
| 2012 Q2 | 59.2 Million USD | 0.68% |
| 2012 Q4 | 67.2 Million USD | 7.52% |
| 2012 Q3 | 62.5 Million USD | 5.57% |
| 2011 FY | 221.7 Million USD | 3.94% |
| 2011 Q1 | 57.3 Million USD | -0.17% |
| 2011 Q2 | 56.2 Million USD | -1.92% |
| 2011 Q3 | 54 Million USD | -3.91% |
| 2011 Q4 | 53.5 Million USD | -0.93% |
| 2010 Q1 | 52.7 Million USD | 2.93% |
| 2010 FY | 213.3 Million USD | 7.95% |
| 2010 Q4 | 57.4 Million USD | 12.55% |
| 2010 Q3 | 51 Million USD | -2.49% |
| 2010 Q2 | 52.3 Million USD | -0.76% |
| 2009 Q3 | 49.4 Million USD | -0.6% |
| 2009 Q4 | 51.2 Million USD | 3.64% |
| 2009 FY | 197.6 Million USD | 2.97% |
| 2009 Q2 | 49.7 Million USD | 5.3% |
| 2009 Q1 | 47.2 Million USD | 15.97% |
| 2008 Q3 | 46.1 Million USD | 0.66% |
| 2008 Q4 | 40.7 Million USD | -11.71% |
| 2008 Q1 | 44.4 Million USD | 28.32% |
| 2008 FY | 191.9 Million USD | 13.82% |
| 2008 Q2 | 45.8 Million USD | 3.15% |
| 2007 Q2 | 41.8 Million USD | 2.45% |
| 2007 Q4 | 34.6 Million USD | -32.68% |
| 2007 Q1 | 40.8 Million USD | -8.52% |
| 2007 FY | 168.6 Million USD | 4.85% |
| 2007 Q3 | 51.4 Million USD | 22.97% |
| 2006 Q4 | 44.6 Million USD | 14.07% |
| 2006 Q1 | 38.7 Million USD | 18.71% |
| 2006 FY | 160.8 Million USD | 32.13% |
| 2006 Q2 | 38.4 Million USD | -0.78% |
| 2006 Q3 | 39.1 Million USD | 1.82% |
| 2005 Q3 | 30.7 Million USD | -4.36% |
| 2005 FY | 121.7 Million USD | 14.06% |
| 2005 Q4 | 32.6 Million USD | 6.19% |
| 2005 Q2 | 32.1 Million USD | 22.05% |
| 2005 Q1 | 26.3 Million USD | 70.78% |
| 2004 Q3 | 30.3 Million USD | -2.88% |
| 2004 FY | 106.7 Million USD | 13.15% |
| 2004 Q2 | 31.2 Million USD | 4.7% |
| 2004 Q4 | 15.4 Million USD | -49.17% |
| 2004 Q1 | 29.8 Million USD | 508.16% |
| 2003 Q3 | 28.9 Million USD | -5.56% |
| 2003 FY | 94.3 Million USD | 16.42% |
| 2003 Q2 | 30.6 Million USD | 2.34% |
| 2003 Q1 | 29.9 Million USD | 39.72% |
| 2003 Q4 | 4.9 Million USD | -83.04% |
| 2002 Q3 | 19.7 Million USD | -7.08% |
| 2002 FY | 81 Million USD | 12.66% |
| 2002 Q1 | 18.7 Million USD | 23.84% |
| 2002 Q2 | 21.2 Million USD | 13.37% |
| 2002 Q4 | 21.4 Million USD | 8.63% |
| 2001 Q3 | 18.8 Million USD | -1.05% |
| 2001 Q4 | 15.1 Million USD | -19.68% |
| 2001 Q1 | 19.3 Million USD | -64.13% |
| 2001 Q2 | 19 Million USD | -1.55% |
| 2001 FY | 71.9 Million USD | -31.33% |
| 2000 Q3 | 16.5 Million USD | -2.94% |
| 2000 Q1 | 17.4 Million USD | -69.84% |
| 2000 FY | 104.7 Million USD | -7.83% |
| 2000 Q2 | 17 Million USD | -2.3% |
| 2000 Q4 | 53.8 Million USD | 226.06% |
| 1999 Q4 | 57.7 Million USD | 200.52% |
| 1999 Q1 | 17 Million USD | -23.08% |
| 1999 Q2 | 19.7 Million USD | 15.88% |
| 1999 Q3 | 19.2 Million USD | -2.54% |
| 1999 FY | 113.6 Million USD | 10.51% |
| 1998 Q4 | 22.1 Million USD | 27.75% |
| 1998 Q3 | 17.3 Million USD | -5.98% |
| 1998 FY | 102.8 Million USD | 0.69% |
| 1998 Q1 | 45 Million USD | -7.6% |
| 1998 Q2 | 18.4 Million USD | -59.11% |
| 1997 Q3 | 16.3 Million USD | -14.66% |
| 1997 FY | 102.1 Million USD | -1.35% |
| 1997 Q1 | 18 Million USD | -62.66% |
| 1997 Q2 | 19.1 Million USD | 6.11% |
| 1997 Q4 | 48.7 Million USD | 198.77% |
| 1996 Q1 | 19.1 Million USD | -59.87% |
| 1996 Q3 | 18.1 Million USD | 0.0% |
| 1996 Q4 | 48.2 Million USD | 166.3% |
| 1996 FY | 103.5 Million USD | 4.02% |
| 1996 Q2 | 18.1 Million USD | -5.24% |
| 1995 Q3 | 16.6 Million USD | -8.29% |
| 1995 Q1 | 16.8 Million USD | -61.9% |
| 1995 Q2 | 18.1 Million USD | 7.74% |
| 1995 Q4 | 47.6 Million USD | 186.75% |
| 1995 FY | 99.5 Million USD | 8.03% |
| 1994 Q3 | 15.6 Million USD | -7.69% |
| 1994 Q4 | 44.1 Million USD | 182.69% |
| 1994 FY | 92.1 Million USD | 7.72% |
| 1994 Q1 | 15.5 Million USD | -60.96% |
| 1994 Q2 | 16.9 Million USD | 9.03% |
| 1993 FY | 85.5 Million USD | 5.95% |
| 1993 Q1 | 14.9 Million USD | -62.37% |
| 1993 Q2 | 15.8 Million USD | 6.04% |
| 1993 Q3 | 15.1 Million USD | -4.43% |
| 1993 Q4 | 39.7 Million USD | 162.91% |
| 1992 FY | 80.7 Million USD | -26.3% |
| 1992 Q4 | 39.6 Million USD | 176.92% |
| 1992 Q3 | 14.3 Million USD | 3.62% |
| 1992 Q2 | 13.8 Million USD | 6.15% |
| 1992 Q1 | 13 Million USD | -81.32% |
| 1991 Q3 | 12.3 Million USD | -10.22% |
| 1991 Q2 | 13.7 Million USD | -1.44% |
| 1991 Q1 | 13.9 Million USD | -67.14% |
| 1991 FY | 109.5 Million USD | 36.02% |
| 1991 Q4 | 69.6 Million USD | 465.85% |
| 1990 Q4 | 42.3 Million USD | 258.47% |
| 1990 Q1 | 13 Million USD | 104.77% |
| 1990 FY | 80.5 Million USD | 22.15% |
| 1990 Q3 | 11.8 Million USD | -11.94% |
| 1990 Q2 | 13.4 Million USD | 3.08% |
| 1989 FY | 65.9 Million USD | 9.11% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | -272.6 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alcon Inc. | 4.2 Billion USD | 89.211% |
| AptarGroup, Inc. | 814.37 Million USD | 44.252% |
| Baxter International Inc. | 5.27 Billion USD | 91.388% |
| Becton, Dickinson and Company | 6.04 Billion USD | 92.492% |
| Bausch + Lomb Corporation | 2.37 Billion USD | 80.876% |
| Haemonetics Corporation | 526.66 Million USD | 13.797% |
| Envista Holdings Corp | 1.15 Billion USD | 60.546% |
| ResMed Inc. | 1.36 Billion USD | 66.822% |
| Teleflex Incorporated | 1.08 Billion USD | 58.127% |
| Warby Parker Inc. | 437.22 Million USD | -3.838% |